A study of postherpetic pruritus Sir, Postherpetic neuralgia (PHN) is the most common complication of herpes zoster (HZ), affecting approximately 50% of patients older than 60 years and 15% of all HZ patients. [1] Most of these patients complain of pain; which has been studied extensively. Itch is relatively under-reported and therefore, often, a neglected component of PHN. We, therefore, conducted a study on 100 consecutive patients of PHN to determine the burden of postherpetic pruritus (PHP) among them. We defined PHN as pain and/or pruritus persisting 1 month after the onset of zoster rash. Severity of pruritus was assessed on the visual analog scale and rated as mild (1-3), moderate (4-7), and severe (8-10).
The study included 57 males and 43 females. Maximum number of patients belonged to the age group of 61-70 years. The mean duration of PHN was 7.7 months. The longest duration recorded was 7 years in one patient. Interestingly, this patient had only pruritus. Fifty-three out of 100 (53%) patients experienced PHP, of which 54.71%, 28.30%, and 16.94% cases had mild, moderate, and severe pruritus, respectively. Seven cases had only pruritus, whereas the rest had both pain and pruritus [ Table 1 ]. It was noted that a higher proportion of patients with facial zoster had itching, seen in 15 out of 21 (71.4%) patients. Sixteen out of 53 (30.18%) patients also reported associated alloknesis.
In different studies done on PHN, prevalence of PHP varies from 7% to 58%. [2] It is not surprising to see pruritus as a component of PHN because pain and itch are closely related. Itching accompanies pain in several disease states including HZ in its acute phase as well as in PHN. Histological studies of patients with acute HZ and PHN have revealed that cutaneous innervation density is decreased in the affected region [3] and the overall reduction appears more severe in patients who develop PHN. This might leave the affected dermatome relatively enriched in itch fibers extending from adjacent spared dermatomes, thus resulting in neuropathic itch. [2] In our series, 54.71% of patients had mild itching, whereas 16.94% had severe itching. Severe itch can sometimes have devastating consequences. One of the classical examples include a patient with intractable PHP of the V1 dermatome who gradually and unintentionally went on scratching. This intractable painless scratching was probably a result of profound cutaneous denervation due to HZ, which resulted in loss of protective pain sensation. Severe scratching resulted in skull bone defect, subsequently leading to epidural abscess, hemiparesis, seizures, and personality changes due to frontal lobe injury. [4, 5] In conclusion, we experienced that a significant proportion of patients with PHN also suffer from itching, which is more likely in case of facial HZ. Most of these patients are fortunate enough to have mild-to-moderate itch, but few may have severe, disabling itch. Therefore, pruritus must be given adequate focus while managing a case of PHN. One must also remember that pain and itch may have to be treated differently, for example, opioids relieve neuropathic pain, but can cause or worsen itch. [5] Financial support and sponsorship Nil.
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Extrafacial melasma over forearms
Sir, Melasma is a common hypermelanoses affecting the female gender. The etiology of melasma has not been clearly identified. Factors associated with melasma include exposure to ultraviolet light, pregnancy, oral contraceptives, hormone replacement therapy, thyroid autoimmunity, cosmetic ingredients, and phototoxic drugs. [1] The commonest site affected by melasma is the face and has been distinguished into three clinical patterns, namely, centrofacial, malar, and mandibular. Extrafacial melasma is a rare entity and has been very rarely reported in the literature. Extrafacial melasma should be distinguished from acquired brachial cutaneous dyschromatosis (ABCD). [2] A 55-year-old woman presented with brownish pigmentation of her both forearms for past six years. She reported that initially few brown hyperpigmented asymptomatic spots appeared on her right forearm and similar pigmented spots started appearing on the other forearm too. She denied any history of inflammatory dermatoses prior to appearance of her skin problem. The patient was postmenopausal since three years. She reported that the pigmentation became more prominent on sun exposure. She denied the intake of oral contraceptive pills or hormone replacement therapy. There was no history suggestive of thyroid dysfunction. She did not give history of receiving any photosensitizing drugs. Cutaneous examination showed a large, brown irregular patch on her right forearm and a similar developing lesion on her other forearm. The patches comprised of multiple coalescing hyperpigmented macules with irregular borders with intervening areas showing normal skin. She also had malar type of facial melasma [ Figure 1 ]. We made a provisional diagnosis of extrafacial melasma and ABCD. Potassium hydroxide mount from the patches failed to show any fungal elements, which ruled out pityriasis versicolor. Wood's lamp examination showed accentuation of pigmentation suggestive of epidermal pigmentation. Skin biopsy from the lesion showed epidermal thinning and increased melanization of basal layer [ Figure 2 ]. Histology showed minimal epidermal atrophy and mild solar elastosis in the form of elastic fiber degeneration. No evidence of amyloid material was seen on special stains, which ruled out frictional amyloid deposition. On a review of the literature, we were able to rule out acquired brachial cutaneous dyschromatosis as there were no hypopigmented atrophic macules. On correlation, we made a diagnosis of extrafacial melasma involving dorsa of both forearms.
Extrafacial melasma is an uncommon variant of melasma and has been very rarely reported in the literature. Extrafacial melasma shares similar clinical features as that of facial melasma with brownish hyperpigmented spots with irregular borders. Although facial and extrafacial melasma share some clinical features, they differ in incidence. Melasma occurs predominantly in the age group of 20-40 years with a mean age of 33 years and is rarely observed in menopausal females. [3] Extrafacial melasma is known to affect menopausal women in the fifth decade of life. [4] 
